News

Featured news from NHIVNA

HIV-related news from NAM

NNRTIs and protease inhibitors both good for first ART, channelling affects choices
Liz Highleyman, 2014-10-22 08:00:00

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) and boosted protease inhibitors work equally well for people starting HIV treatment for the first time, with similar viral suppression, CD4 cell gains, and disease progression, according to a large meta-analysis presented at IDWeek 2014 earlier this month in Philadelphia, United States. A related study shed light on factors affecting choice of initial antiretroviral regimen.

Source:1